Press Releases

The following are official statements issued by UsAgainstAlzheimer’s in response to major national policy actions, industry events, breaking news, or organizational achievements. Please see the UsAgainstAlzheimer’s press kit page for additional information. For media requests, please contact Chantez Bailey at [email protected].

  • April 15, 2025

    European Union Approves Leqembi, Marking Major Step Forward in Alzheimer’s Treatment

    Read more
  • April 02, 2025

    UsAgainstAlzheimer’s joins more than 20 leading neurological advocacy organizations to urge immediate halt to funding and staffing cuts

    Read more
  • April 02, 2025

    UsAgainstAlzheimer’s Warns Against Cuts that Threaten Alzheimer’s Research and Treatment

    Read more
  • March 27, 2025

    Potential Cuts to Health Agencies Could Upend Decades of Progress Toward a Cure for Alzheimer’s Disease

    Read more
  • March 07, 2025

    UsAgainstAlzheimer’s Board Member to Speak at Stand Up for Science Rally

    Read more
  • February 26, 2025

    UsAgainstAlzheimer’s Urges Senate to Reject Harmful Medicaid Cuts That Threaten Alzheimer's Care and Progress

    Read more
  • February 20, 2025

    UsAgainstAlzheimer’s Calls on Congress to Protect and Continue Investment in Alzheimer’s Research and Treatment

    Read more
  • February 14, 2025

    Coalition of Groups Representing Tens of Millions of Patients Calls for Protection of the Nation’s Vital Health Infrastructure

    Read more
  • January 27, 2025

    UsAgainstAlzheimer’s Applauds FDA Approval of Leqembi® Monthly Dosing

    UsAgainstAlzheimer’s chair and co-founder George Vradenburg issued the following statement in response...

    Read more

Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer's. This report found that deep social inequities exist in countries highly impacted by Alzheimer's among Latinos and Blacks.

Read Report